Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals is a China-based innovative pharmaceutical company headquartered in Hangzhou, Zhejiang. Its operations span research, development, manufacturing and commercialization of prescription therapeutics, with strong historical emphasis on targeted cancer treatments. The company also pursues additional discovery technologies and external research collaborations to address unmet medical needs. Betta is listed on the Shenzhen Stock Exchange under security code 300558. Its drug development activities include small-molecule medicines and selected biologic collaborations.
Company at a glance
Corporate information
- Company entity
- Betta Pharmaceuticals Co., Ltd.
- Headquarters / principal office
- China
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.bettapharma.com/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
SZSE: 300558
targeted small molecules · antibody collaborations · protein degraders
oncology · ophthalmology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Betta Pharmaceuticals is a China-based innovative pharmaceutical company headquartered in Hangzhou, Zhejiang. Its operations span research, development, manufacturing and commercialization of prescription therapeutics, with strong historical emphasis on targeted cancer treatments. The company also pursues additional discovery technologies and external research collaborations to address unmet medical needs. Betta is listed on the Shenzhen Stock Exchange under security code 300558. Its drug development activities include small-molecule medicines and selected biologic collaborations.
Business, technology & evidence
- SecuritiesSZSE: 300558
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Betta Pharmaceuticals Co., Ltd. ↗Betta Pharmaceuticals Co., Ltd. ·
- Official issuer and R&D disclosure · Betta Pharmaceuticals Co., Ltd. ↗Betta Pharmaceuticals Co., Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.